Filing Details
Immunome Inc. (NASDAQ:IMNM) filed a Form 8-K with the Securities and Exchange Commission on October 05, 2026, disclosing a material event.
8k filedNASDAQ:IMNM
Immunome Inc. (IMNM) Reports Material Event to SEC
Immunome Inc. (NASDAQ:IMNM) filed a Form 8-K with the Securities and Exchange Commission on October 05, 2026, disclosing a material event.
At publication ·
What changed
Immunome Inc. (NASDAQ:IMNM) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Immunome Inc. filed a Form 8-K with the SEC on October 5, 2026, disclosing a material event requiring shareholder notification.
- The company's stock trades at $21.17 with a market capitalization of $1.8 billion.
- 8-K filings report significant events such as leadership changes, acquisitions, asset sales, or guidance changes between regular reports.
Market Context
Immunome Inc.'s stock currently trades at $21.17 with a market capitalization of $1.8B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Immunome Inc.'s stock.
All SEC filings for Immunome Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View IMNM Stock Page
Frequently Asked Questions
Where can I read IMNM's SEC filings?
Browse all filings on our IMNM SEC filings page.
What types of SEC filings does Immunome Inc. file?
Public companies like Immunome Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.